Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA055879-05
Application #
2096971
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1992-02-01
Project End
1997-01-31
Budget Start
1996-02-01
Budget End
1997-01-31
Support Year
5
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Arkansas for Medical Sciences
Department
Pathology
Type
Schools of Medicine
DUNS #
City
Little Rock
State
AR
Country
United States
Zip Code
72205
Kaushal, G P; Xiong, X; Athota, A B et al. (1999) Syndecan-1 expression suppresses the level of myeloma matrix metalloproteinase-9. Br J Haematol 104:365-73
Liu, W; Litwack, E D; Stanley, M J et al. (1998) Heparan sulfate proteoglycans as adhesive and anti-invasive molecules. Syndecans and glypican have distinct functions. J Biol Chem 273:22825-32
Stanley, M J; Liebersbach, B F; Liu, W et al. (1995) Heparan sulfate-mediated cell aggregation. Syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells. J Biol Chem 270:5077-83
Sanderson, R D; Turnbull, J E; Gallagher, J T et al. (1994) Fine structure of heparan sulfate regulates syndecan-1 function and cell behavior. J Biol Chem 269:13100-6
San Antonio, J D; Karnovsky, M J; Gay, S et al. (1994) Interactions of syndecan-1 and heparin with human collagens. Glycobiology 4:327-32
Sneed, T B; Stanley, D J; Young, L A et al. (1994) Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells. Cell Immunol 153:456-67
Liebersbach, B F; Sanderson, R D (1994) Expression of syndecan-1 inhibits cell invasion into type I collagen. J Biol Chem 269:20013-9
Ridley, R C; Xiao, H; Hata, H et al. (1993) Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood 81:767-74
Sanderson, R D; Sneed, T B; Young, L A et al. (1992) Adhesion of B lymphoid (MPC-11) cells to type I collagen is mediated by integral membrane proteoglycan, syndecan. J Immunol 148:3902-11